Lilly's Baricitinib Delivered High Rates Of Hair Regrowth For Adolescents With Severe Alopecia Areata In Phase 3 BRAVE-AA-PEDS Study
Late-breaking results presented at AAD show 80% or more scalp hair coverage at Week 36 in 42.4% of adolescents receiving baricitinib 4 mg ...
We hear a lot about women’s health. Here’s the essential guide for dads, partners, friends
As a father, partner, brother, work colleague, friend, there will be women in your life whom you care about. With the array ...
Business Day2d
Under the Surface: A Tale of Skin, Acne, and Resilience
Amara tried to focus on her work. But her mind was elsewhere, her reflection in the mirror earlier that day was haunting her.
Gehost op MSN5d
A look at life-saving advancements to help fight colorectal cancer
March is National Colorectal Cancer Awareness month so Dr. Andrea Cercek, a medical oncologist at Memorial Sloan Kettering ...
Montreal Gazette6d
AAD 2025: Galderma to Present Extensive Updates From Across Its Dermatology Portfolio, Demonstrating Its Category Leadership and Strong Momentum
New data on Nemluvio® (nemolizumab), including an oral e-poster presentation characterizing the impact of Nemluvio in different pruriginous lesion types in prurigo nodularis from the phase III OLYMPIA ...